English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduYale Cancer Center (YCC) and Smilow Cancer Hospital physicians and scientists will share new data for breakthrough and emerging cancer treatments as well as new discoveries in obesity, tobacco, evolution, and early onset cancers in early April at the American Association for Cancer Research (AACR) annual meeting.
Tag: Cancer Treatments
Montefiore Einstein Comprehensive Cancer Center Awarded Comprehensive Designation from the National Cancer Institute
The newly renamed Montefiore Einstein Comprehensive Cancer Center (MECCC) has been awarded comprehensive designation by the National Cancer Institute (NCI) of the National Institutes of Health, the ultimate standard achieved by only 55 other NCI cancer centers in the U.S.
Research raises hopes for new treatment of fusion-driven cancer
A new study presents a promising treatment method for so-called fusion-driven cancers, which are currently often difficult to cure. These fusion-driven cancers are caused by an error in cell division that creates a fusion of different genes. This fusion causes the cancer and drives the uncontrolled cell growth.
Study identifies potential treatment target for prostate cancer resistant to hormone therapy
Prostate cancer is the most-commonly diagnosed malignancy and the second leading cause of cancer death among men in the United States. In its ever-indelicate world, the stubborn disease can continue to grow even when the amount of testosterone in the body is reduced to very low levels, thus earning the clumsy name: castrate-resistant prostate cancer (CRPC).
Researchers use Artificial Intelligence to personalise cancer patient treatments
Researchers at the University of Sussex are using Artificial Intelligence (AI) technology to analyse different types of cancer cells to understand different gene dependencies, and to identify genes that are critical to a cell’s survival.
Scientists develop new device to detect brain tumors using urine
Researchers at Nagoya University in Japan have used a new device to identify a key membrane protein in urine that indicates whether the patient has a brain tumor.
‘Molecular Twin’ Initiative Will Help Advance Precision Cancer Treatment
Cedars-Sinai Cancer and Tempus, a leader in artificial intelligence and precision medicine, are harnessing the power of big data and AI to design personalized cancer treatment options by creating virtual replicas of patients’ DNA, RNA, protein and other information to help identify the most effective approach to each individual’s disease.
New grant, National Fellowship for UA Little Rock Nanotechnology Researcher
Dr. K. Bao Vang-Dings, a nanotechnology researcher at the University of Arkansas at Little Rock, has been named one of nine 2021-22 Public Policy Fellows by the American Association of Immunologists. Additionally, the Arkansas IDeA Network of Biomedical Research Excellence (INBRE) has awarded her a 2021 Summer Research Grant to support Vang-Dings’ cancer vaccine research.
Henry Ford Health System Kicks Off David DiChiera Music Therapy Program with Detroit Symphony Orchestra and Michigan Opera Theatre
Henry Ford Health System, in partnership with the Detroit Symphony Orchestra (DSO) and Michigan Opera Theatre (MOT), has begun offering virtual musical performances to cancer patients via its music therapy program named for the founding general director of Michigan Opera Theatre, David DiChiera. Through the David DiChiera Music Therapy Program, patients of Henry Ford Cancer Institute will be able to enjoy both live and archived virtual performances from the DSO and MOT at no cost.
NUS researchers discover breakthrough in cancer diagnosis using big data analytics
A team of researchers from the National University of Singapore has developed a personalised assessment tool which can detect the incidence of cancer, predict patient survivability and determine patient suitability for immunotherapy cancer treatment.